PUBLICATIONS

Full list of publications can be found at: https://www.scopus.com/authid/detail.uri?authorId=35221395700

2024

2023

2022

  • Abdelgalil RM, Elmorshedy YM, Elkhodairy KA, Teleb M, Bekhit AA, Khattab SN, Elzoghby AO, Engineered Nanomedicines for Augmenting the Efficacy of Colorectal Cancer Immunotherapy, Nanomedicine (Lond) 17 (2022) 1721–1745. https://pubmed.ncbi.nlm.nih.gov/36621872/
  • Atallah MA, Sallam MA, Abdelmoneem MA, Teleb M, Elkhodairy KA, Bekhit AA, Khafaga AF, Noreldin AE, Elzoghby AO, Khattab SN, Green Self-assembled Lactoferrin Carboxymethyl Cellulose Nanogels for Synergistic Chemo/herbal Breast Cancer Therapy, Colloids Surf B Biointerfaces 217 (2022) 112657. https://pubmed.ncbi.nlm.nih.gov/35803031/
  • Mokhtar S, Khattab SN, Elkhodairy KA, Teleb M, Bekhit AA, Elzoghby AO, Sallam MA, Methotrexate-lactoferrin targeted exemestane cubosomes for synergistic breast cancer therapy, Front Chem 10 (2022) 1-15. https://pubmed.ncbi.nlm.nih.gov/35392419/
  • Salah M, Sallam MA, Abdelmoneem, MA, Teleb M, Elkhodairy KA, Bekhit AA, Khafaga AF, Noreldin AE, Elzoghby AO, Khattab SN, Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment, Pharmaceutics 14 (2022) 2404. https://pubmed.ncbi.nlm.nih.gov/36365222/

2021

  • Anwar DM, Elsayed M, Reda AM, Khattab SN, Fang J-Y, Elzoghby AO, Recent advances in herbal combination nanomedicine for cancer: Delivery technology and therapeutic outcomes, Expert Opin Drug Deliv 18(11) (2021) 1609–1625. https://pubmed.ncbi.nlm.nih.gov/34254868/
  • Hafez DA, Hassanin EA, Teleb M, Khattab SN, Elkhodairy KA, Elzoghby AO, Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy, Nanomedicine (Lond) 16(25) (2021) 2305–2325. https://pubmed.ncbi.nlm.nih.gov/34551585/
  • Abdelhamid AS, Zayed DG, Heikal L, Khattab SN, Elgizawy S, Elzoghby AO, Recent advances in polymer shell-oily core nanocapsules for drug delivery applications, Nanomedicine (Lond) 16(18) (2021) 1613–1625. https://pubmed.ncbi.nlm.nih.gov/34189946/
  • Khafaga AF, Shamma RN, Abdeen A, Barakat AM, Noreldin AE, Elzoghby AO, Sallam MA, Celecoxib repurposing in cancer Therapy: Molecular mechanisms and nanomedicine-based delivery technologies, Nanomedicine (Lond) 16(19) (2021) 1691–1712. https://pubmed.ncbi.nlm.nih.gov/34264123/
  • Metawea ORM, Abdelmoneem MA, Haiba NS, Khalil HH, Teleb M, Elzoghby AO, Khafaga AF, Noreldin AE, Albericio F, Khattab SN, A novel ‘smart’ PNIPAM-based copolymer for breast cancer targeted therapy; synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA, Colloids Surf B Biointerfaces 192 (2021), 202, 111694. https://pubmed.ncbi.nlm.nih.gov/33740633/
  • Abdelmoneem MA, Abd Elwakil MM, Abdulkader MA, Zaky A, Helmy MW, Khattab SN, Bekhit AA, Teleb M, Elkhodairy KA, Albericio F, Elzoghby AO, Lactoferrin-Dual Drug Nanoconjugate: Synergistic Anti-Tumor Efficacy of Docetaxel and the NF-κB Inhibitor Celastrol, Materials Science & Engineering C 118 (2021) 111422. https://pubmed.ncbi.nlm.nih.gov/33255023/

2020

  • Elzoghby AO, Abdelmoneem MA, Hassanin IA, Abd Elwakil MM, Elnaggar M, Mokhtar S, Fang JY, Elkhodairy KA, Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand, Biomaterials 263 (2020) 120355. https://pmc.ncbi.nlm.nih.gov/articles/PMC7480805/
  • Rofeal MG, Elzoghby AO, Helmy MW, Khalil R, Khairy H, Omar S, Dual therapeutic targeting of lung infection and carcinoma using lactoferrin-based green nanomedicine, ACS Biomater Sci Eng 6(10) (2020) 5685–5699. https://pubs.acs.org/doi/10.1021/acsbiomaterials.0c01095
  • Elhasany K, Khattab SN, Bekhit AA, Ragab DM, Abdulkader MA, Zaky A, Helmy MW, Ashour HMA, Haiba NS, Teleb M, Elzoghby AO, Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy, Eur J Pharm Biopharm 155 (2020) 162-176. https://pubmed.ncbi.nlm.nih.gov/32818610/
  • Hassanin EA, Elzoghby AO, Self-Assembled Non-Covalent Protein-Drug Nanoparticles: Emerging Delivery Platform for Anti-Cancer Drugs, Expert Opin Drug Deliv 4 (2020) 1-22. https://pubmed.ncbi.nlm.nih.gov/32820954/
  • Abdelaziz HM, Elzoghby AO, Helmy MW, Samaha MW, Fang JY, Freag MS, Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting, ACS Biomater Sci Eng 6(2) (2020) 1030-1042. https://pubs.acs.org/doi/10.1021/acsbiomaterials.9b01639
  • Hafez DA, Elkhodairy KA, Teleb M, Elzoghby AO, Nanomedicine-Based Approaches for Improved Delivery of Phyto-Therapeutics for Cancer Therapy, Expert Opin Drug Deliv 17(3) (2020) 279-285. https://pubmed.ncbi.nlm.nih.gov/31997666/
  • Kamel NM, Helmy MW, Elsayeda-Zeinab A, Khattab SN, Ragab DM, Samaha MW, Fang JY, Elzoghby AO, Inhalable dual-targeted hybrid lipid nanocore-protein shell composites for combined delivery of genistein and all-trans retinoic acid to lung cancer cells, ACS Biomater Sci Eng 6 (2020) 71−87. https://pubs.acs.org/doi/10.1021/acsbiomaterials.8b01374
  • Gaber M, Elhasany K, Saly Sabra, Helmy MW, Fang JY, Khattab SN, Bekhit AA, Teleb M, Elkodairy K, Elzoghby AO, Co-Administration of Tretinoin Enhances the Anti-Cancer Efficacy of Etoposide via Tumor-Targeted Green Nano-Micelles, Colloids Surf B Biointerfaces 192 (2020) 110997. https://pubmed.ncbi.nlm.nih.gov/32361378/
  • Yu H-P, Liu F-C, Umoro A, Lin Z-C, Elzoghby AO, Hwang T-L, Fang J-Y, Oleic acid-based nanosystems for mitigating acute respiratory distress syndrome in mice through neutrophil suppression: how the particulate size affects therapeutic efficiency, J Nanobiotechnology 18(1) (2020) 25. https://pubmed.ncbi.nlm.nih.gov/32005196/
  • Ali OM, Bekhit AA, Khattab SN, Helmy MW, Abdel-Ghany YS, Teleb M, Elzoghby AO, Synthesis of Lactoferrin Mesoporous Silica Nanoparticles for Pemetrexed/Ellagic Acid Synergistic Breast Cancer Therapy, Colloids Surf B Biointerfaces 188 (2020) 110824. https://pubmed.ncbi.nlm.nih.gov/32023511/
  • Nafee N, Gaber DM, Elzoghby AO, Helmy MW, Abdallah OY, Promoted antitumor activity of myricetin against lung carcinoma via nanoencapsulated phospholipid complex in respirable microparticles, Pharm Res 37(4) (2020) 82. https://link.springer.com/article/10.1007/s11095-020-02794-z
  • Kamel NM, Samaha MW, Elzoghby AO, El-Kimary EI, Sensitive Inexpensive HPLC Determination of Novel Anticancer Combination in Nanoparticles and Rat Plasma: Pharmacokinetic Application, J Chromatogr Sci. 58 (2020) 334-345. https://pubmed.ncbi.nlm.nih.gov/32043118/

2019

  • Abdelmoneem MA, Elnaggar MA, Hammady RS, Kamel SM, Helmy MW, Abdulkader MA, Zaky A, Fang JY, Elkhodairy KA, Elzoghby AO, Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma. ACS Appl Mater Interfaces 11(30) (2019), 26731-26744. https://pubs.acs.org/doi/10.1021/acsami.9b10164
  • Lin CY, Hsu CY, Elzoghby AO, Alalaiwe A, Hwang TL, Fang JY, Oleic acid as the active agent and lipid matrix in cilomilast-loaded nanocarriers to assist PDE4 inhibition of activated neutrophils for mitigating psoriasis-like lesions, Acta Biomater. 90 (2019) 350-361. https://pubmed.ncbi.nlm.nih.gov/30951898/
  • Gaber M, Hany M, Mokhtar S, Helmy MW, Elkodairy KA, Elzoghby AO, Boronic-Targeted Albumin-Shell Oily-Core Nanocapsules for Synergistic Aromatase Inhibitor/Herbal Breast Cancer Therapy, Materials Science & Engineering C 105 (2019) 110099. https://pubmed.ncbi.nlm.nih.gov/31546395/
  • Kamel NM, Helmy MW, Ragab D, Samaha MW, Elzoghby AO, Multi-compartmental lipid-protein nanohybrids for combined tretinoin/herbal lung cancer therapy. Nanomedicine (Lond) 14(18) (2019) 2461-2479. https://pubmed.ncbi.nlm.nih.gov/31456481/
  • Elzoghby AO, Freag MS, Toward improving drug delivery research in Egypt: Cancer Nanotechnology Research Laboratory as a role model, Drug Discov Today 24 (2019) 361-363. https://pubmed.ncbi.nlm.nih.gov/30439448/
  • Elzoghby AO, Pharmaceutical nanotechnology in Egypt: Diverse applications and promising outcomes, Nanomedicine (Lond) 14(6) (2019) 649-653. https://pubmed.ncbi.nlm.nih.gov/30693819/
  • Zayed DG, AbdElhamid AS, Freag MS, Elzoghby AO, Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery & cancer imaging, Nanomedicine (Lond) 14 (2019) 225-228. https://pubmed.ncbi.nlm.nih.gov/30652951/
  • Sabra SA, Sheweita SA, Haroun M, Ragab D, Eldemellawy MA, Xia Y, Goodale D, Allan AL, Elzoghby AO, Rohani S, Magnetically-guided self-assembled protein micelles for enhanced delivery of dasatinib to human triple negative breast cancer cells, J Pharm Sci 108 (2019) 1713-1725. https://pubmed.ncbi.nlm.nih.gov/30528944/
  • Zayed DG, Ebrahim SM, Helmy MW, Khattab SN, Bahey-El-Din M, Fang JY, Elkhodairy KA, Elzoghby AO, Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: Covalent coupling & phospholipid complexation approaches, J Nanobiotechnology 17 (2019) 7-26. https://pubmed.ncbi.nlm.nih.gov/30660179/
  • Abdelaziz HM, Elzoghby AO, Helmy MW, Samaha MW, Fang JY, Freag MS, Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells, Int J Nanomedicine 14 (2019) 499–517. https://pubmed.ncbi.nlm.nih.gov/30666110/

2018

  • Abdelmoneem MA, Mahmoud M, Zaky A, Helmy MW, Sallam M, Fang JY, Elkhodairy KA, Elzoghby AO, Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma, J Control Release 287 (2018) 78-93. https://pubmed.ncbi.nlm.nih.gov/30138716/
  • Elgohary MM, Helmy MW, Abdelfattah EZ, Ragab DM, Mortada SM, Fang JY, Elzoghby AO, Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy, J Control Release 285 (2018) 230-243. https://pubmed.ncbi.nlm.nih.gov/30009892/
  • Gaber Mohamed, Mabrouk MT, Freag MS, Khiste SK, Fang JY, Elkhodairy KA, Elzoghby AO, Protein-polysaccharide nanohybrids: Hybridization techniques and drug delivery applications, Eur J Pharm Biopharm 133 (2018) 42-62. https://www.sciencedirect.com/science/article/abs/pii/S093964111830821X
  • Anwar DM, Khattab SN, Helmy MW, Kamal MK, Bekhit AA, Elkhodairy KA, Elzoghby AO, Lactobionic/folate dual-targeted amphiphilic maltodextrin-based micelles for targeted co-delivery of sulfasalazine and resveratrol to hepatocellular carcinoma, Bioconjug Chem 29(9) (2018) 3026-3041. https://pubmed.ncbi.nlm.nih.gov/30110148/
  • AbdElhamid AS, Helmy MW, Ebrahim SM, Bahey-El-Din M, Zayed DG, Zein El Dein EA, El-Gizawy SA, Elzoghby AO, Lactoferrin-tagged QDs-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer, Nanomedicine (Lond) 13(20) (2018) 2637-2656. https://pubmed.ncbi.nlm.nih.gov/30338705/
  • Abd Elwakil MM, Mabrouk MT, Helmy MW, Abdelfattah EZ, Khiste SK, Elkhodairy KA, Elzoghby AO, Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma, Nanomedicine (Lond) 13(16) (2018) 2015-2035. https://pubmed.ncbi.nlm.nih.gov/30191764/
  • Abdelmoneem MA, Mahmoud M, Zaky A, Helmy MW, Sallam M, Fang JY, Elkhodairy KA, Elzoghby AO, Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma, Nanomedicine (Lond) 13(19) (2018) 2377-2395. https://pubmed.ncbi.nlm.nih.gov/30346255/
  • El-Lakany SA, Helmy MW, Abu-Serie MM, Elgindy NA, Elzoghby AO, Lactoferrin-decorated vs PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer. Expert Opin Drug Deliv 15(9) (2018) 835-850. https://pubmed.ncbi.nlm.nih.gov/30067113/
  • Elgohary MM, Helmy MW, Mortada SM, Elzoghby AO, Dual-targeted nano-in-nano albumin carriers enhance the efficacy of combined chemo/herbal therapy of lung cancer, Nanomedicine (Lond) 13(17) (2018) 2221-2224. https://pubmed.ncbi.nlm.nih.gov/30265215/
  • Chen CH, Chen CJ, Elzoghby AO, Yeh TS, Fang JY, Self-assembly and directed assembly of lipid nanocarriers for prevention of liver fibrosis in obese rats, Nanomedicine (Lond) 13 (2018) 1551–1566. https://pubmed.ncbi.nlm.nih.gov/29998778/
  • AbdElhamid AS, Helmy MW, Ebrahim SM, Bahey-El-Din M, Zayed DG, Zein El Dein EA, El-Gizawy SA, Elzoghby AO, Layer-by-layer gelatin/chondroitin QD-based nano-theranostics: Combined rapamycin/celecoxib delivery and cancer imaging, Nanomedicine (Lond) 13(14), (2018) 1707–1730. https://pubmed.ncbi.nlm.nih.gov/30073915/
  • Kabary DM, Helmy MW, Abdelfattah EZ, Fang JY, Elkhodairy KA, Elzoghby AO, Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma, Eur J Pharm Biopharm 130 (2018) 152-164. https://pubmed.ncbi.nlm.nih.gov/29964122/
  • El-Far SW, Helmy MW, Khattab SN, Bekhit AA, Hussein AA, Elzoghby AO, Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungal & herbal derived anticancer drugs, Nanomedicine (Lond) 13 (2018) 1463-1480. https://pubmed.ncbi.nlm.nih.gov/29957120/
  • Sabra SA, Elzoghby AO, Sheweita SA, Haroun M, Helmy MW, Eldemellawy MA, Xia Y, Goodale D, Allan AL, Rohani S, Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted codelivery of rapamycin and wogonin to breast cancer, Eur J Pharm Biopharm 128 (2018) 156–169. https://pubmed.ncbi.nlm.nih.gov/29957120/
  • Kabary DM, Helmy MW, Elkhodairy KA, Fang JY, Elzoghby AO, Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma, Colloids Surf B Biointerfaces 169 (2018) 183-194. https://pubmed.ncbi.nlm.nih.gov/29775813/
  • Liu FC, Yu HP, Lin CY, Elzoghby AO, Hwang TL, Fang JY, Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge, J Nanobiotechnology 30;16(1) (2018) 35. https://pubmed.ncbi.nlm.nih.gov/29602314/
  • El-Far SW, Helmy MW, Khattab SN, Bekhit AA, Hussein AA, Elzoghby AO, Phytosomal bilayer enveloped casein micelles for co-delivery of monascus yellow pigments & resveratrol to breast cancer, Nanomedicine (Lond) 13 (2018) 481-499. https://pubmed.ncbi.nlm.nih.gov/29376765/
  • Abdelaziz HM, Gaber M, Abd-Elwakil MM, Mabrouk MT, Elgohary MM, Kamel NM, Kabary DM, Freag MS, Samaha MW, Mortada SM, Elkhodairy KA, Fang JY, Elzoghby AO, Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates. J Control Release 269 (2018) 374-392. https://pubmed.ncbi.nlm.nih.gov/29180168/
  • Sallam MA, Elzoghby AO, Flutamide loaded zein nanocapsules hydrogel, a promising dermal delivery system for pilosebaceous unit disorders, AAPS PharmSciTech 19 (2018) 2370–2382. https://pubmed.ncbi.nlm.nih.gov/29882189/
  • Agwa MM, Elessawy FEM, Abd Elrehim HA, Eldemellawy MA, Elzoghby AO, Abd El-Salam MH, Eldiwany AI, Development and validation of an analytical robust method to quantify both etoposide and prodigiosin in polymeric nanoparticles by reverse-phase high-performance liquid chromatography, Anal. Methods 10 (2018) 2272-2280. https://pubs.rsc.org/en/content/articlelanding/2018/ay/c8ay00030a

2017

  • Elzoghby AO, El-Lakany SA, Helmy MW, Abu-Serie MM, Elgindy NA, Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy, Nanomedicine (Lond) 12 (2017) 2785-2805. https://pubmed.ncbi.nlm.nih.gov/29094642/
  • Gaber M, Medhat W, Hany M, Saher N, Fang JY, Elzoghby AO, Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes, J Control Release 254 (2017) 75–91. https://pubmed.ncbi.nlm.nih.gov/28365294/
  • Freag MS, Elzoghby AO, Protein-inorganic nanohybrids: A potential symbiosis in tissue engineering, Curr Drug Targets 19 (2017) 1897-1904. https://pubmed.ncbi.nlm.nih.gov/29076428/
  • Chen CH, Huang TH, Elzoghby AO, Sung CT, Wang PW, Chang CW, Fang JY, Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification, Int J Nanomedicine 12 (2017) 8071-8083. https://pubmed.ncbi.nlm.nih.gov/29138563/
  • Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S, Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy, Int J Pharm 529 (2017) 178-192. https://pubmed.ncbi.nlm.nih.gov/28663087/
  • Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S, Multi-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapy, Pharm Res 34 (2017) 1956–1969. https://pubmed.ncbi.nlm.nih.gov/28643236/
  • Sabra SA, Abdelmoneem MA, Abdelwakil MM, Taha M, Anwar D, Mohamed R, Elkhodairy KA, Freag MS, Elzoghby AO, Self-assembled nanocarriers based on amphiphilic natural polymers for anti-cancer drug delivery applications, Curr Pharm Des 23 (35), (2017) 5213-5229. (Editor’s Choice) https://pubmed.ncbi.nlm.nih.gov/28552068/
  • Elzoghby AO, Mamdouh H, Elkhodairy KA, Freag MS, Zein-based nanocarriers as potential natural alternatives for drug and gene delivery: Focus on cancer therapy, Curr Pharm Des 23 (35), (2017) 5261-5271. https://pubmed.ncbi.nlm.nih.gov/28641543/
  • Elzoghby AO, Editorial: Polymeric nanocarriers as robust platforms for cancer therapy, Curr Pharm Des 23 (35), (2017), 5211-5212. https://pubmed.ncbi.nlm.nih.gov/29110600/

2016

2015

  • Elzoghby AO, Vranic BZ, Samy WM, Elgindy NA, Swellable floating tablet based on spray-dried casein nanoparticles: Near-infrared spectral characterization and floating matrix evaluation, Int J Pharm 491 (2015) 113–122. https://pubmed.ncbi.nlm.nih.gov/26095913/

2014

  • Elgindy NA, Helmy MW, Samy WM, Elzoghby AO, Editorial: Casein-based micelles: a novel vector for delivery of the poorly soluble anticancer drug flutamide, Ther Deliv 5 (2014) 7–9. https://pubmed.ncbi.nlm.nih.gov/24341810/

2013

  • Elzoghby AO, Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. J Control Release 172 (2013) 1075–1091. https://www.sciencedirect.com/science/article/abs/pii/S0168365913008079
  • Elzoghby AO, Saad NI, Helmy MW, Samy WM, Elgindy NA, Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anti-cancer activity in prostate cancer-bearing rats, Eur J Pharm Biopharm 85 (2013) 444–451. https://www.sciencedirect.com/science/article/abs/pii/S0939641113002488
  • Elzoghby AO, Helmy MW, Samy WM, Elgindy NA, Micellar delivery of flutamide by spray-dried milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model, Pharm Res 30 (2013) 2654–2663. https://pubmed.ncbi.nlm.nih.gov/23739989/
  • Elzoghby AO ⃰, Helmy MW, Samy WM, Elgindy NA, Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization and in vivo pharmacokinetics, Eur J Pharm Biopharm 84 (2013) 487–496. https://pubmed.ncbi.nlm.nih.gov/23403015/
  • Elzoghby AO, Samy WM, Elgindy NA, Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride, Pharm Res 30 (2013) 512–522. https://pubmed.ncbi.nlm.nih.gov/23135815/
  • Elzoghby AO, Helmy MW, Samy WM, Elgindy NA, Novel ionically-crosslinked casein nanoparticles for flutamide delivery: Formulation, characterization and in vivo pharmacokinetics, Int J Nanomedicine 8 (2013) 1721–1732. https://pubmed.ncbi.nlm.nih.gov/23658490/

2012

  • Elzoghby AO, Samy WM, Elgindy NA, Albumin-based nanoparticles as potential controlled release drug delivery systems, J Control Release 157 (2012) 168–182. (2012 Pharma Sciences Editor’s Choice). https://pubmed.ncbi.nlm.nih.gov/21839127/
  • Elzoghby AO, Samy WM, Elgindy NA, Protein-based nanocarriers as promising drug and gene delivery systems, J Control Release 161 (2012) 38–49. https://pubmed.ncbi.nlm.nih.gov/22564368/
  • Elgindy NA, Elkhodairy KA, Molokhia AM, Elzoghby AO, Impact of different formulation variables on the biodegradability, surface area and porosity of biopolymeric microparticles, J Tissue Eng Regen Med 6 (2012) 13. https://core.ac.uk/download/55624039.pdf

2011

2010

  • Elgindy NA, Elkhodairy KA, Molokhia AM, Elzoghby AO, Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide, Eur J Pharm Biopharm 74 (2010) 397–405. https://pubmed.ncbi.nlm.nih.gov/19944160/

Book Chapters

Scroll to Top